NDC17478-0040-01 (Lorazepam Injection) by Akorn Inc - Request a Quote Now

Part No. : NDC17478-0040-01 Alternate P/N : NDC17478004001 Manufacturer : Akorn Inc
CAGE Code : 55751 Item Name : Lorazepam Injection NSN : 6505-01-650-2681

You can send a request for quote for p/n NDC17478-0040-01 to ASAP Semiconductor using justpartsunlimited.com. This part is manufactured by Akorn Inc (CAGE Code 55751). The description of it is Lorazepam Injection. The national stock number associated with this part is NSN 6505016502681. This part belongs to FSC  part family. An associate from ASAP Semiconductor will respond within 15 minutes to your query. It is our pleasure to help you with NDC17478-0040-01 part requirements.

Required fields compulsory *

Contact Information

Note: We will not share your information to any third parties.

  * By clicking this box, I acknowledge that I have read and accept the ASAP Semiconductor Terms & Conditions and agree that all quotes and purchase orders are exclusively subject to the ASAP Semiconductor Terms and Conditions.

  • I consent to receive email communications from ASAP Semiconductor and can unsubscribe at any time.
  • ASAP Semiconductor is a wholly independent aftermarket parts distributor.
  • This website is intended for quotations based on part numbers only. Please DO NOT submit drawings, technical data, or other specifications through this portal.

NSN Information for Part Number NDC17478-0040-01 with NSN 6505-01-650-2681, 6505016502681

NSNFSCNIINCLSHazmatDEMILCancelled NSN
6505-01-650-2681

Item Description:

Lorazepam Injection

6505016502681MP
CIICHCCESDPMICCriticalityENAC
Q A0
Part NumberISCRNVCRNCCHCCMSDSSADC
Ndc17478-0040-01523

Characteristics Data of NSN 6505-01-650-2681, 6505016502681

MRCCriteriaCharacteristic
AJCNIII PROTECTIVE STORAGE FEATUREREQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
AKJAACTIVE MEDICAMENT MEDICINAL STRENGTH2.0 MILLIGRAMS LORAZEPAM PER MILLIGRAM
AKJQPHARMACEUTICAL VEHICLE TYPEAQUEOUS
CQCTPRIMARY CONTAINER TYPEVIAL
CRLKPRIMARY CONTAINER CONTENT QUANTITY2.0 MILLILITERS
CRYCIII CONTROLLED SUBSTANCE CLASSIFICATIONSCHEDULE IV
CSCWTOTAL PRIMARY CONTAINER QUANTITY10
CSGSADMINISTRATIONINTRAVENOUS AND INTRAMUSCULAR
CXCYIII PART NAME ASSIGNED BY CONTROLLING AGENCYATIVAN INJECTION 2 MG/ML VIAL 1 ML, 10 VIALS PER PACKAGE
FEATSPECIAL FEATURESLORAZEPAM 2 MG-ML VL 10X1 ML; SCHEDULE IV DEA CONTROLLED SUBSTANCE; INTENDED FOR THE INTRAMUSCULAR OR INTRAVENOUS ROUTES OF ADMINISTRATION; EACH ML OF STERILE INJECTION CONTAINS EITHER 2 MILLIGRAMS OF LORAZEPAM; CONCENTRATION/STRENGTH: 2 MG
ASAP Semiconductor's Certifications and Memberships